7TM PHARMA
7TM Pharma is a biotech company that discovers and develops drugs with a primary therapeutic focus on diabetes, gastrointestinal, metabolic, asthma, and vascular diseases. The company offers seven transmembrane-spanning receptors, including TM38837, a small molecule CB1 receptor antagonist; TM30339, a NPY Y4 selective agonist that is used within gastrointestinal disorders, and short bowel syndrome; and CRTH2 antagonist, an oral drug for inflammatory or respiratory diseases. 7TM Pharma was founded in 2000 and is based in Lyngby, Hovedstaden.
7TM PHARMA
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
2000-01-01
Address:
Lyngby, Hovedstaden, Denmark
Country:
Denmark
Status:
Closed
Contact:
(453)925-7777
Total Funding:
82.67 M USD
Current Advisors List
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2006-05-24 | CareX SA | CareX SA acquired by 7TM Pharma | N/A |
Investors List
Alta Partners
Alta Partners investment in Venture Round - 7TM Pharma
SR One
SR One investment in Venture Round - 7TM Pharma
Index Ventures
Index Ventures investment in Venture Round - 7TM Pharma
LD Pensions
LD Pensions investment in Venture Round - 7TM Pharma
Johnson & Johnson Development Corporation
Johnson & Johnson Development Corporation investment in Venture Round - 7TM Pharma
Scottish Widows Investment Partnership
Scottish Widows Investment Partnership investment in Series D - 7TM Pharma
Alta Partners
Alta Partners investment in Series D - 7TM Pharma
Novo Holdings
Novo Holdings investment in Series D - 7TM Pharma
SR One
SR One investment in Series D - 7TM Pharma
Dansk Innovation
Dansk Innovation investment in Series D - 7TM Pharma